Subtle changes in ADMA and l‐arginine concentrations in normal pregnancies are unlikely to account for pregnancy‐related increased flow‐mediated dilatation

Background:  Our objective was to investigate whether serum concentrations of asymmetric dimethylarginine (ADMA) or l‐arginine correlate to hyperlipidemia or endothelial function in normal pregnancy compared with the non‐pregnant subjects.

[1]  T. Laitinen,et al.  Brachial Artery Flow-Mediated Dilation and Asymmetrical Dimethylarginine in the Cardiovascular Risk in Young Finns Study , 2007, Circulation.

[2]  T. Laitinen,et al.  Pregnancy-related hyperlipidemia and endothelial function in healthy women. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[3]  E. Schwedhelm,et al.  Comparison of HPLC method and commercial ELISA assay for asymmetric dimethylarginine (ADMA) determination in human serum. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[4]  D. Fliser,et al.  Asymmetrical Dimethylarginine in Idiopathic Pulmonary Arterial Hypertension , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[5]  R. Olszanecki,et al.  Effects of prolonged oral supplementation with l‐arginine on blood pressure and nitric oxide synthesis in preeclampsia , 2005, European journal of clinical investigation.

[6]  J. Viikari,et al.  The 21‐year follow‐up of the Cardiovascular Risk in Young Finns Study: risk factor levels, secular trends and east–west difference , 2004, Journal of internal medicine.

[7]  G. Remuzzi,et al.  l-Arginine Depletion in Preeclampsia Orients Nitric Oxide Synthase Toward Oxidant Species , 2004, Hypertension.

[8]  P. López-Jaramillo,et al.  Plasma concentrations of asymmetric dimethylarginine (ADMA) in Colombian women with pre-eclampsia. , 2004, JAMA.

[9]  H. Ishizaka,et al.  High plasma level of asymmetric dimethylarginine in patients with acutely exacerbated congestive heart failure: role in reduction of plasma nitric oxide level , 2003, Heart and Vessels.

[10]  A. Hingorani,et al.  Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia , 2003, The Lancet.

[11]  H. Okamura,et al.  Asymmetric Dimethylarginine, an Endogenous Inhibitor of Nitric Oxide Synthase, in Maternal and Fetal Circulation , 2003, The Journal of the Society for Gynecologic Investigation: JSGI.

[12]  齋藤 正之.  High plasma level of asymmetric dimethylarginine in patients with acutely exacerbated congestive heart failure : Role in reduction of plasma nitric oxide level , 2003 .

[13]  R. Nijveldt,et al.  Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. , 2002, Analytical biochemistry.

[14]  J P Cooke,et al.  Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus. , 2001, The American journal of cardiology.

[15]  A. Hamsten,et al.  Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine. , 2001, Journal of the American College of Cardiology.

[16]  N. Butte.  Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. , 2000, The American journal of clinical nutrition.

[17]  K. Thornburg,et al.  Hemodynamic changes in pregnancy. , 2000, Seminars in perinatology.

[18]  Ian G. Charles,et al.  Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases. , 1999, The Biochemical journal.

[19]  P. Vallance,et al.  Biological significance of endogenous methylarginines that inhibit nitric oxide synthases. , 1999, Cardiovascular research.

[20]  K. Sørensen,et al.  Normal pregnancy is associated with enhanced endothelium-dependent flow-mediated vasodilation. , 1999, American journal of physiology. Heart and circulatory physiology.

[21]  H. Masuda,et al.  Accelerated intimal hyperplasia and increased endogenous inhibitors for NO synthesis in rabbits with alloxan‐induced hyperglycaemia , 1999, British journal of pharmacology.

[22]  P. Tsao,et al.  Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. , 1998, Circulation.

[23]  T. Hedner,et al.  Increased circulating concentrations of asymmetric dimethyl arginine (ADMA), an endogenous inhibitor of nitric oxide synthesis, in preeclampsia , 1998, Acta obstetricia et gynecologica Scandinavica.

[24]  S. Nussey,et al.  Plasma concentrations of asymmetric dimethylarginine, a natural inhibitor of nitric oxide synthase, in normal pregnancy and preeclampsia. , 1998, American journal of obstetrics and gynecology.

[25]  L. Poston,et al.  Flow-mediated vasodilatation is enhanced in normal pregnancy but reduced in preeclampsia. , 1997, Hypertension.

[26]  S. Moncada,et al.  Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure , 1992, The Lancet.

[27]  Douglas G. Altman,et al.  Practical statistics for medical research , 1990 .

[28]  M. Kimoto,et al.  Purification and properties of a new enzyme, NG,NG-dimethylarginine dimethylaminohydrolase, from rat kidney. , 1989, The Journal of biological chemistry.